ACIU MEXC RealStocks
Own real ACIU shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 00:42:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
AC Immune SA (ACIU) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.14, with a market capitalization of $227.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.02 to $3.90. This page covers its latest market performance, valuation, price trends and company information.
$227.69M | |
$2.21 | |
$2.26 | |
$2.13 | |
$2.26 | |
117.24K | |
199.75K | |
-- | |
$3.90 | |
$2.02 | |
-- | |
-- |
AC Immune SA (ACIU) is trading at $2.15 in after-hours trading as of 2026-11-13 00:31:00, up 0.23% ($0.00) from the regular-session close of $2.14.
After-hours trading shows how investors are pricing ACIU after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, AC Immune SA (ACIU) moved from $2.09 to $2.14, representing a gain of 2.39% ($0.05).
The stock traded between $2.02 and $2.55 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 235.24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 6.6%
ACIU is currently trading at $2.14, placing it 6.6% of the way from its 52-week low of $2.02 to its 52-week high of $3.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
| Employees | 122 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for AC Immune SA.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of AC Immune SA (ACIU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ACIU, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ACIU shares and USD.
ACIU Shares to USD
1.00 ACIU shares = 2.14 USD
Calculations are estimates based on the latest available price and are for reference only.